US Stock Insider Trading | Viemed Healthcare Discloses 14 Insider Transactions on February 2

K-LinePoet · 2026-02-04T11:23:50+00:00

On February 2, 2026, Viemed Healthcare disclosed multiple insider transactions, with directors and executives selling a large number of shares on January 29, and director Hoyt Casey selling as many as 27,200 shares. Viemed focuses on providing high-level care for patients with respiratory diseases.

K-LinePoet

2026-02-04 11:23:50

Abstract generation in progress

On February 2, 2026, Viemed Healthcare (VMD) disclosed 14 insider trading transactions. Director Hoyt Casey sold 13,900 shares on January 29, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 2, 2026	Executive	Moore Michael	January 29, 2026	Sell	16,300	7.48	$121,800
February 2, 2026	Director	ZEHNDER WILLIAM TODD	January 29, 2026	Sell	20,300	7.48	$152,000
February 2, 2026	Executive	Fitzgerald Trae	January 29, 2026	Sell	5,944	7.48	$44,500
February 2, 2026	Executive	Trahan Jeremy	January 29, 2026	Sell	6,530	7.48	$48,800
February 2, 2026	Director	Hoyt Casey	January 29, 2026	Sell	27,200	7.48	$203,300
February 2, 2026	Executive	Cambre Jerome	January 29, 2026	Sell	5,228	7.48	$39,100
February 2, 2026	Director	Frazier William	January 29, 2026	Sell	1,580	7.48	$11,800
January 23, 2026	Executive	Cambre Jerome	January 21, 2026	Sell	6,757	7.49	$50,600
January 23, 2026	Executive	Moore Michael	January 21, 2026	Sell	17,900	7.49	$134,200
January 23, 2026	Director	Hoyt Casey	January 21, 2026	Sell	26,000	7.49	$194,500

【Company Information】

Viemed Healthcare, Inc. was incorporated on December 14, 2016. Viemed operates through its wholly owned subsidiaries Sleep Management, L.L.C. (“Sleep Management”) and Home Sleep Delivered, L.L.C. (“Home Sleep,” and together with Sleep Management, “Sleepco subsidiaries”), which are Medicare durable medical equipment suppliers providing post-acute respiratory services in the United States. Viemed’s primary focus is on the business of the Sleepco subsidiaries to strengthen its position as one of the leading home treatment providers for patients with respiratory diseases requiring high levels of care. These programs are specifically designed for payers and capable of treating patients while reducing overall costs and delivering high-quality care. The services offered by the Sleepco subsidiaries include respiratory disease management, neuromuscular care, home sleep testing, sleep apnea treatment, oxygen therapy, and respiratory equipment leasing.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.